"Clínica Ricardo Palma | Por 3er año consecutivo somos la mejor clínica en el Perú y la número 14 en Latinoamérica"

During the past decade, Clinica Ricardo Palma conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 5 clinical trials were completed, i.e. on average, 31.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 3 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinica Ricardo Palma" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Merck Sharp & Dohme LLC" with 4 trials sponsored, "Arcus Biosciences, Inc." with 1 trials sponsored, "Celldex Therapeutics" with 1 trials sponsored and "Daiichi Sankyo, Inc." with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinica Ricardo Palma" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Clinica Ricardo Palma" are "Chronic Cough" (4 trials), "Breast Cancer" (2 trials), "Non-Small Cell Lung Cancer" (2 trials), "Breast Cancer Stage IIIA" (1 trials) and "Breast Cancer Stage IV" (1 trials). Many other conditions were trialed in "Clinica Ricardo Palma" in a lesser frequency.

Most popular intervention types in "Clinica Ricardo Palma" are "Drug" (19 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Atezolizumab" (4 trials), "Docetaxel" (3 trials), "Gefapixant" (3 trials) and "Paclitaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Clinica Ricardo Palma" are 15 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Clinica Ricardo Palma". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Clinica Ricardo Palma, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Clinica Ricardo Palma, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".